Taha Kass-Hout - Mar 1, 2024 Form 4 Insider Report for GE HealthCare Technologies Inc. (GEHC)

Role
Chief Technology Officer
Signature
/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact
Stock symbol
GEHC
Transactions as of
Mar 1, 2024
Transactions value $
$0
Form type
4
Date filed
3/5/2024, 05:52 PM
Previous filing
Feb 6, 2024
Next filing
May 29, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GEHC Common Stock, par value $0.01 per share Award $0 +9.98K +16.46% $0.00 70.6K Mar 1, 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GEHC Employee Stock Option (right to buy) Award $0 +28.4K $0.00 28.4K Mar 1, 2024 Common Stock, par value $0.01 per share 28.4K $92.72 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 33% will vest on September 1, 2025, 33% will vest on September 1, 2026, and 34% will vest on September 1, 2027, subject to certain conditions.
F2 Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.
F3 Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions.